JP5302200B2 - オキサゾリジノン誘導体および使用方法 - Google Patents

オキサゾリジノン誘導体および使用方法 Download PDF

Info

Publication number
JP5302200B2
JP5302200B2 JP2009533406A JP2009533406A JP5302200B2 JP 5302200 B2 JP5302200 B2 JP 5302200B2 JP 2009533406 A JP2009533406 A JP 2009533406A JP 2009533406 A JP2009533406 A JP 2009533406A JP 5302200 B2 JP5302200 B2 JP 5302200B2
Authority
JP
Japan
Prior art keywords
compound
formula
deuterium
linezolid
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2009533406A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010507576A (ja
JP2010507576A5 (enExample
Inventor
スコット ハーベソン
ロジャー タン
Original Assignee
コンサート ファーマシューティカルズ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by コンサート ファーマシューティカルズ インコーポレイテッド filed Critical コンサート ファーマシューティカルズ インコーポレイテッド
Publication of JP2010507576A publication Critical patent/JP2010507576A/ja
Publication of JP2010507576A5 publication Critical patent/JP2010507576A5/ja
Application granted granted Critical
Publication of JP5302200B2 publication Critical patent/JP5302200B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
JP2009533406A 2006-10-23 2007-10-23 オキサゾリジノン誘導体および使用方法 Expired - Fee Related JP5302200B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US85389006P 2006-10-23 2006-10-23
US60/853,890 2006-10-23
US97463707P 2007-09-24 2007-09-24
US60/974,637 2007-09-24
PCT/US2007/022516 WO2008127300A2 (en) 2006-10-23 2007-10-23 Oxazolidinone derivatives and methods of use

Publications (3)

Publication Number Publication Date
JP2010507576A JP2010507576A (ja) 2010-03-11
JP2010507576A5 JP2010507576A5 (enExample) 2010-12-09
JP5302200B2 true JP5302200B2 (ja) 2013-10-02

Family

ID=39864509

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009533406A Expired - Fee Related JP5302200B2 (ja) 2006-10-23 2007-10-23 オキサゾリジノン誘導体および使用方法

Country Status (5)

Country Link
US (1) US20080139563A1 (enExample)
EP (1) EP2099299A4 (enExample)
JP (1) JP5302200B2 (enExample)
CA (1) CA2703011A1 (enExample)
WO (1) WO2008127300A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8796267B2 (en) * 2006-10-23 2014-08-05 Concert Pharmaceuticals, Inc. Oxazolidinone derivatives and methods of use
US20080146573A1 (en) * 2006-12-04 2008-06-19 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted oxzolidinones
US20090062283A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched linezolid
US8354557B2 (en) * 2008-06-17 2013-01-15 Concert Pharmaceuticals, Inc. Synthesis of deuterated morpholine derivatives
NZ599151A (en) * 2009-10-13 2014-07-25 Melinta Therapeutics Inc Pharmaceutical composition comprising radezolid or salt thereof and uses thereof
CN104327004A (zh) * 2014-11-17 2015-02-04 重庆华邦制药有限公司 高纯度利奈唑胺氮氧化物的制备方法
KR101811437B1 (ko) * 2015-09-17 2018-01-25 서울대학교산학협력단 그람 음성균에 대한 항균 활성을 나타내는 끊어진 또는 꺾어진 나선 펩타이드 또는 펩타이드 유사체 및 이의 용도
US20170145002A1 (en) * 2015-11-25 2017-05-25 Astrazeneca Ab Deuterated isoxazole derivatives and their use as metabotropic glutamate receptor potentiators
US11608320B2 (en) 2020-02-02 2023-03-21 Kuwait University Oxazolidinone hydroxamic acid derivatives

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
US6221335B1 (en) * 1994-03-25 2001-04-24 Isotechnika, Inc. Method of using deuterated calcium channel blockers
EP1019385B1 (en) * 1995-09-15 2004-01-14 PHARMACIA & UPJOHN COMPANY Aminoaryl oxazolidinone n-oxides
US6255304B1 (en) * 1997-05-30 2001-07-03 Pharmacia & Upjohn Company Oxazolidinone antibacterial agents having a thiocarbonyl functionality
US6884429B2 (en) * 1997-09-05 2005-04-26 Isotechnika International Inc. Medical devices incorporating deuterated rapamycin for controlled delivery thereof
EP1049682A1 (en) * 1998-01-23 2000-11-08 Versicor, Inc. Oxazolidinone combinatorial libraries, compositions and methods of preparation
US6440710B1 (en) * 1998-12-10 2002-08-27 The Scripps Research Institute Antibody-catalyzed deuteration, tritiation, dedeuteration or detritiation of carbonyl compounds
EP1104760B1 (en) * 1999-12-03 2003-03-12 Pfizer Products Inc. Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
AR027261A1 (es) * 2000-02-02 2003-03-19 Upjohn Co Linezolid forma cristalina ii
EP1231209A1 (en) * 2000-12-19 2002-08-14 Specialized Pharmaceutical Research Ltd. Co. Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compound
TW200413273A (en) * 2002-11-15 2004-08-01 Wako Pure Chem Ind Ltd Heavy hydrogenation method of heterocyclic rings
TWI410409B (zh) * 2005-07-26 2013-10-01 Takeda Gmbh 同位素取代之潘托拉唑（ｐａｎｔｏｐｒａｚｏｌｅ）
JP5301991B2 (ja) * 2005-07-29 2013-09-25 コンサート ファーマシューティカルズ インコーポレイテッド 新規なベンゾ［ｄ］［１，３］−ジオキソール誘導体
CA2624179A1 (en) * 2005-10-06 2007-04-12 Auspex Pharmaceuticals, Inc. Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
US7750168B2 (en) * 2006-02-10 2010-07-06 Sigma-Aldrich Co. Stabilized deuteroborane-tetrahydrofuran complex
CA2661404A1 (en) * 2006-09-05 2008-03-13 Schering Corporation Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis
US8796267B2 (en) * 2006-10-23 2014-08-05 Concert Pharmaceuticals, Inc. Oxazolidinone derivatives and methods of use
US20080146573A1 (en) * 2006-12-04 2008-06-19 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted oxzolidinones

Also Published As

Publication number Publication date
WO2008127300A2 (en) 2008-10-23
EP2099299A4 (en) 2011-11-30
CA2703011A1 (en) 2008-10-23
JP2010507576A (ja) 2010-03-11
US20080139563A1 (en) 2008-06-12
WO2008127300A3 (en) 2008-12-11
EP2099299A2 (en) 2009-09-16

Similar Documents

Publication Publication Date Title
JP5302200B2 (ja) オキサゾリジノン誘導体および使用方法
US8796267B2 (en) Oxazolidinone derivatives and methods of use
JP5389028B2 (ja) 置換オキサゾリジノン誘導体
US8198305B2 (en) 1,2-benzisoxazol-3-yl compounds
US9108902B2 (en) Deuterated 2-amino-3-hydroxypropanoic acid derivatives
JP2010507593A (ja) ３−（ジヒドロ−１Ｈ−ピラゾロ［４，３−ｄ］ピリミジン−５−イル）−４−プロポキシベンゼンスルホンアミド誘導体および使用方法
US9708277B2 (en) Inhibitors of cholesterol ester transfer protein
JP2012508738A (ja) 置換ジオキソピペリジニルフタルイミド誘導体
JP2010241825A (ja) ナフチル（エチル）アセトアミド
WO2014011971A2 (en) Deuterated carfilzomib
US20080280913A1 (en) Tetrahydrotriazolopyrazine derivatives and uses thereof
US20080318969A1 (en) Anti-anginal compounds
AU2014237569B2 (en) Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase
EP2197847B1 (en) Deuterated 4 -oxoquinoline derivative for the treatment of hiv infection
JP2014527962A (ja) Ｔ型カルシウムチャネル遮断薬としてのテトラヒドロナフタレン誘導体
US9107922B2 (en) Pyrimidinecarboxamide derivatives
US20110152227A1 (en) Deuterium labelled derivatives of 3-(2-hydroxy-5-methyphenyl)-n,n-diisopropyl-3-phenylpropylamine and methods of use thereof
WO2009140279A2 (en) Sulfonyl urea compounds
WO2010002451A1 (en) Naphthyridin derivatives
HK1158614A (en) Derivatives of 3-(2-hydroxy-5-methylphenyl)-n,n-diisopropyl-3-phenylpropylamine and methods of use thereof
WO2010036773A1 (en) Deuterated l-aryl-2 -aminomethyl cyclopropane carboxyamide derivatives

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101020

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20101020

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121204

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130226

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130305

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130404

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20130405

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130618

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130620

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees